WEBVTT - Deutz Buy, Astrazeneca's Trial, Computacenter Up

0:00:02.520 --> 0:00:07.360
<v Speaker 1>Bloomberg Audio Studios, Podcasts, radio News.

0:00:08.560 --> 0:00:12.440
<v Speaker 2>The Stock Movers Report, your roundup of companies making moves

0:00:12.480 --> 0:00:15.880
<v Speaker 2>in the stock market, harnessing the power of Bloomberg Data.

0:00:16.560 --> 0:00:18.800
<v Speaker 3>Now, let's have a look out these stocks that are

0:00:18.840 --> 0:00:21.400
<v Speaker 3>on the move today here in Europe. On Caroline Hepkar

0:00:21.520 --> 0:00:23.520
<v Speaker 3>with Lizzie Burton and we joined by Bloomberg Report. To

0:00:23.560 --> 0:00:28.360
<v Speaker 3>Chloe Malay. Good morning, Chloe. Let's talk about a German company,

0:00:28.400 --> 0:00:32.280
<v Speaker 3>an engine maker, which is making a push into defense.

0:00:32.320 --> 0:00:34.199
<v Speaker 3>We just had the NATO summit, we just had the

0:00:34.200 --> 0:00:37.040
<v Speaker 3>announcement of more spending. There's a lot of focus on

0:00:37.080 --> 0:00:37.720
<v Speaker 3>this sector.

0:00:38.040 --> 0:00:40.320
<v Speaker 1>Yes, absolutely, So there's a bit of m and a

0:00:40.440 --> 0:00:43.360
<v Speaker 1>there from Deuts. So the German company Deuts, which makes

0:00:43.400 --> 0:00:47.240
<v Speaker 1>engines for buses, trucks, ships, et cetera. It is buying

0:00:47.360 --> 0:00:51.040
<v Speaker 1>the privately owned defense firm FFG for one point six

0:00:51.120 --> 0:00:52.000
<v Speaker 1>billion euros.

0:00:52.000 --> 0:00:55.080
<v Speaker 4>So FFG makes military vehicles and so.

0:00:55.080 --> 0:00:58.000
<v Speaker 1>That's the way for Deuts to expand more into this

0:00:58.160 --> 0:01:01.480
<v Speaker 1>defense sector and trying to really benefit from this rising

0:01:01.520 --> 0:01:04.760
<v Speaker 1>military spending that we've seen in Europe. And so Duds

0:01:04.760 --> 0:01:07.919
<v Speaker 1>that had already kind of been stepping up this defense push.

0:01:08.080 --> 0:01:11.959
<v Speaker 1>It had acquired stakes in you know, companies like Arx Robotics,

0:01:12.520 --> 0:01:15.920
<v Speaker 1>Titan Technologies which makes drones, and so it said that

0:01:16.240 --> 0:01:18.480
<v Speaker 1>you know, this particular deal, which is much bigger than

0:01:18.560 --> 0:01:21.240
<v Speaker 1>deals that it has done previously, would help it reach

0:01:21.360 --> 0:01:25.240
<v Speaker 1>its twenty thirty targets. Earlier, we've seen this deal making

0:01:25.280 --> 0:01:28.479
<v Speaker 1>activity pick up quite a bit in the defense sector.

0:01:28.720 --> 0:01:30.800
<v Speaker 1>Just earlier this week we had this big a deal

0:01:30.800 --> 0:01:35.320
<v Speaker 1>with Talis buying the drone summarine drone company Excel Technology.

0:01:35.440 --> 0:01:37.560
<v Speaker 1>So it looks like, you know, there's a bit of

0:01:37.600 --> 0:01:40.520
<v Speaker 1>a pick up there in terms of dealmaking activity with

0:01:40.560 --> 0:01:42.840
<v Speaker 1>the deud Steel analysts are saying that it makes sense,

0:01:43.520 --> 0:01:45.600
<v Speaker 1>although they are quite surprised by how big of a

0:01:45.640 --> 0:01:48.360
<v Speaker 1>deal this is. But overall it seems that they're quite

0:01:48.440 --> 0:01:51.680
<v Speaker 1>keen because we've seen the shares are very strongly this morning.

0:01:51.440 --> 0:01:53.120
<v Speaker 5>And Curry the biggest drag on the foot seat six.

0:01:53.200 --> 0:01:55.200
<v Speaker 5>Oh so excuse me on the six stock sectem I'm

0:01:55.240 --> 0:01:58.480
<v Speaker 5>not the foot sea today is Astrozemeka shares down nearly

0:01:58.520 --> 0:02:02.160
<v Speaker 5>ten percent. It comes to a trial for a gene

0:02:02.240 --> 0:02:04.280
<v Speaker 5>silence a drug. What's one of those when it's at home?

0:02:04.560 --> 0:02:09.000
<v Speaker 1>Yeah, So this is due to disappointing clinical trial results

0:02:09.000 --> 0:02:12.560
<v Speaker 1>for Astrasenica. And so the drug in question, it's called

0:02:12.680 --> 0:02:15.560
<v Speaker 1>when you Are it's made in a collaboration with a

0:02:15.600 --> 0:02:19.400
<v Speaker 1>company called Ionis Pharmaceutical and it's a gene silencer. So

0:02:19.440 --> 0:02:23.359
<v Speaker 1>gene silento is something that suppresses the production of abnormal

0:02:23.639 --> 0:02:26.440
<v Speaker 1>proteins in the liver. And so the trial was to

0:02:26.440 --> 0:02:29.360
<v Speaker 1>see if it could also help prevent heart problems in

0:02:29.440 --> 0:02:33.600
<v Speaker 1>patients with a rare version of heart disease. But unfortunately

0:02:33.600 --> 0:02:35.600
<v Speaker 1>when Ya did not manage to do that and to

0:02:35.639 --> 0:02:40.280
<v Speaker 1>reduce cardiovascular events or death related to heart problems. And

0:02:40.320 --> 0:02:43.840
<v Speaker 1>so that's a really big setback for Astrazenica from an

0:02:43.919 --> 0:02:46.959
<v Speaker 1>unex perspective to begin with, because the successful trial could

0:02:47.000 --> 0:02:47.440
<v Speaker 1>have led to.

0:02:47.480 --> 0:02:49.519
<v Speaker 4>Billions of dollars more in cells.

0:02:49.919 --> 0:02:53.200
<v Speaker 1>But it's also strategic setback because Astrasenica has been really

0:02:53.240 --> 0:02:57.200
<v Speaker 1>looking to establish itself in that disease area and that

0:02:57.480 --> 0:03:00.280
<v Speaker 1>particular drug in this particular trial was really a key

0:03:00.320 --> 0:03:03.360
<v Speaker 1>pillar for that. So big setback there, and as we

0:03:03.400 --> 0:03:05.600
<v Speaker 1>can see, the HIRS have taken a major hit on

0:03:05.639 --> 0:03:06.080
<v Speaker 1>the back of that.

0:03:06.440 --> 0:03:10.640
<v Speaker 3>Yeah, so that on astra Zeneca and that disappointing drug

0:03:10.919 --> 0:03:15.120
<v Speaker 3>trial issue. The IT Firm Computer Center now has managed

0:03:15.160 --> 0:03:16.640
<v Speaker 3>to switch investors on.

0:03:16.880 --> 0:03:20.680
<v Speaker 1>Yes, it has so computer Center being this IT services company,

0:03:20.720 --> 0:03:24.360
<v Speaker 1>so essentially supplying laptops to companies in the public sector

0:03:24.360 --> 0:03:26.040
<v Speaker 1>and making sure that they're working properly.

0:03:26.800 --> 0:03:29.120
<v Speaker 4>And this is apparently a great sector to be and

0:03:29.160 --> 0:03:29.560
<v Speaker 4>you know, the.

0:03:30.160 --> 0:03:33.400
<v Speaker 1>Company has had I said that it expects the four

0:03:33.440 --> 0:03:37.040
<v Speaker 1>year results to be comfortably ahead of expectations. It also

0:03:37.080 --> 0:03:40.440
<v Speaker 1>expects the first half profit to be double that of

0:03:40.520 --> 0:03:44.240
<v Speaker 1>last year, and so that is doing very very well.

0:03:44.880 --> 0:03:48.200
<v Speaker 1>And the growth driver has primarily been the US, where

0:03:48.200 --> 0:03:51.600
<v Speaker 1>it's seeing a very very strong demand from hyperscalers that

0:03:51.640 --> 0:03:54.680
<v Speaker 1>are spending a lot on all of all of that,

0:03:55.360 --> 0:03:58.720
<v Speaker 1>and today's share price boost of that was really strong,

0:03:58.920 --> 0:04:02.080
<v Speaker 1>brings THEE to day gains at fifty six percent. So

0:04:02.080 --> 0:04:05.280
<v Speaker 1>it's one of those kind of behind the scenes beneficiaries

0:04:05.320 --> 0:04:08.440
<v Speaker 1>of the AI boom, and it's doing very very well

0:04:08.480 --> 0:04:10.760
<v Speaker 1>and we are seeing that this morning.

0:04:11.520 --> 0:04:15.760
<v Speaker 2>The Stockmovers Report from Bloomberg Radio. Check back with us

0:04:15.800 --> 0:04:18.599
<v Speaker 2>throughout the day for the latest roundup of companies making

0:04:18.680 --> 0:04:22.280
<v Speaker 2>news on Wall Street and for the latest market moving headlines.

0:04:22.480 --> 0:04:26.479
<v Speaker 2>Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg

0:04:26.560 --> 0:04:29.640
<v Speaker 2>dot com, and on Applecarplay and Android Auto with the

0:04:29.640 --> 0:04:31.040
<v Speaker 2>Bloomberg Business App.